NDT Advance Access originally published online on October 18, 2005
Nephrology Dialysis Transplantation 2006 21(2):411-418; doi:10.1093/ndt/gfi198
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Original Articles: Clinical Nephrology
The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France
1 REIN Registry, Agence de la biomédecine, La Plaine Saint Denis, 2 INSERM U258, Research in Cardiovascular and Metabolic Epidemiology Villejuif, 3 Université Paris-Descartes, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris, EA222, Department of Biostatistics and Medical Informatics, Hôpital Necker-Enfants Malades, 4 Limousin coordinator, Nephrology Unit, Centre Hospitalo-Universitaire de Limoges, 5 Languedoc-Roussillon coordinator, Nephrology Unit, Clinique des Genêts, Narbonne, 6 Auvergne coordinator, Nephrology Unit, Centre Hospitalier de Montluçon, 7 Champagne-Ardenne coordinator, Nephrology Unit, Centre Hospitalo-Universitaire de Reims, 8 Bretagne coordinator, Nephrology Unit, Centre Hospitalo-Universitaire, 9 Lorraine coordinator, Nephrology Unit, Centre Hospitalo-Universitaire de Nancy, Vandoeuvre-lès Nancy, 10 Rhône-Alpes coordinator, Centre Hospitalier Lyon-Sud, Nephrology Unit, Centre Hospitalier Lyon-Sud, Pierre-Benite and 11 CIRE Ile de France, InVS, Paris, France
Correspondence and offprint requests to: Dr Cécile Couchoud, REIN, Agence de la biomédecine, 1 avenue du Stade de France, 93212 Saint Denis La Plaine Cedex. Email: cecile.couchoud{at}biomedecine.fr
The French Renal Epidemiology and Information Network (REIN) registry began in 2002 to provide a tool for public health decision support, evaluation and research related to renal replacement therapies (RRT) for end-stage renal disease (ESRD). It relies on a network of nephrologists, epidemiologists, patients and public health representatives, coordinated regionally and nationally. Continuous registration covers all dialysis and transplanted patients. In 2003, 2070 patients started RRT, 7854 were on dialysis and 7294 lived with a functioning graft in seven regions (with a population of 16.5 million people). The overall crude annual incidence rate of RRT for ESRD was 123 per million population (p.m.p.) with significant differences in age-adjusted rates across regions, from 84 [95% confidence interval (CI): 74–94] to 155 [138–172] p.m.p. The principal causes of ESRD were hypertension (21%) and diabetic (20%) nephropathies. Initial treatment for ESRD was peritoneal dialysis for 15% of patients and a pre-emptive graft for 3%. The one-year survival rate was 81% [79–83] in the cohort of 2002–2003 incident patients. As of December 31, 2003, the overall crude prevalence was 898 [884–913] p.m.p, with 5% of patients receiving peritoneal dialysis, 47% on haemodialysis and 48% with a functioning graft. The experience in these seven regions over these two years clearly shows the feasibility of the REIN registry, which is progressively expanding to cover the entire country.
Keywords: end-stage renal disease registry; epidemiology; network; renal replacement therapy; public health decisional support systems; quality control
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Koukourgianni, J. Harambat, B. Ranchin, S. Euvrard, R. Bouvier, A. Liutkus, and P. Cochat Malignancy incidence after renal transplantation in children: a 20-year single centre experience Nephrol. Dial. Transplant., October 10, 2009; (2009) gfp497v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bayat, M. Kessler, S. Briancon, and L. Frimat Survival of transplanted and dialysed patients in a French region with focus on outcomes in the elderly Nephrol. Dial. Transplant., September 11, 2009; (2009) gfp469v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Couchoud, M. Labeeuw, O. Moranne, V. Allot, V. Esnault, L. Frimat, B. Stengel, and for the French Renal Epidemiology and Information A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1553 - 1561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Moranne, L. Watier, J. Rossert, B. Stengel, and The GN-Progress Study Group Primary glomerulonephritis: an update on renal survival and determinants of progression QJM, March 1, 2008; 101(3): 215 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kessler, F. Zannad, P. Lehert, J. P. Grunfeld, C. Thuilliez, A. Leizorovicz, P. Lechat, and for the FOSIDIAL Investigators Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in Dialysis study Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3573 - 3579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Couchoud, O. Moranne, L. Frimat, M. Labeeuw, V. Allot, and B. Stengel Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3246 - 3254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Villar, L. Remontet, M. Labeeuw, R. Ecochard, and on behalf of the Association Regionale des Nephrol Effect of Age, Gender, and Diabetes on Excess Death in End-Stage Renal Failure J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2125 - 2134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Villar, P. Boissonnat, L. Sebbag, A. Hendawy, R. Cahen, P. Trolliet, M. Labeeuw, R. Ecochard, and C. Pouteil-Noble Poor prognosis of heart transplant patients with end-stage renal failure Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1383 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bayat, L. Frimat, N. Thilly, C. Loos, S. Briancon, and M. Kessler Medical and non-medical determinants of access to renal transplant waiting list in a French community-based network of care Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2900 - 2907. [Abstract] [Full Text] [PDF]
|
|